Preliminary Study Examining Heart Failure Patients Responses to Depression Education
NCT ID: NCT01794598
Last Updated: 2014-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
270 participants
INTERVENTIONAL
2004-05-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with chronic heart failure are enrolled into this study with a half of them are randomly assigned to receive a packet of depression education materials and then other half not. Participants and investigators both are blinded to the assignment. All the participants are provided a toll free phone number to contact the research team as needed. Depressive symptoms and patients knowledge of depression are assessed at baseline prior to randomization and at 1-month and 6-month following the enrollment.
Responses of the study participants, such as change of depressive symptoms, and requests for psychiatric help are examined between two groups.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Depression and Self-care in Heart Failure
NCT01028625
Management of Depression and Anxiety in HF
NCT04636944
Stepped Care for Depression in Heart Failure
NCT02997865
How the Elderly Live With Pain in Heart Failure
NCT01794728
Helping Others Toward Positive Emotions in People With Heart Failure
NCT01275742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Educational materials
Receiving educational materials of depression care
Receiving educational material of depression care
The educational material provides patients about depression management
No educational materials
Receiving an envelope but no inclusion of educational materials of depression care
Receiving educational material of depression care
The educational material provides patients about depression management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Receiving educational material of depression care
The educational material provides patients about depression management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* NYHA class II, III, or IV heart failure for the previous three months despite a minimum of 6 weeks of treatment.
* Must be on optimal heart failure therapy according to AHA/ACC and HFSA heart failure guidelines, including treatment with ACEI and beta-blocker therapy, or have documented rationale for variation, including intolerance, contraindication, patient preference, or personal physician's judgment.
Exclusion Criteria
* Currently pregnant or intending to become pregnant in the next year.
* Cardiovascular procedure or hospitalization for any reason planned in the next 6 months.
* Expectation of receiving a cardiac transplant in the next six months.
* Unable to provide the study consent.
* Participation another clinical trial(s) that may interfere with follow-up or data collection for this study, or that may affect cardiovascular mortality.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei Jiang, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5132-03-8R0ER
Identifier Type: OTHER
Identifier Source: secondary_id
5132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.